Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 1,410 KRW
Change Today +40.00 / 2.92%
Volume 1.3M
As of 2:20 AM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

aminologics co ltd (074430) Snapshot

Open
1,385
Previous Close
1,370
Day High
1,470
Day Low
1,355
52 Week High
04/13/15 - 1,620
52 Week Low
10/31/14 - 1,050
Market Cap
103.3B
Average Volume 10 Days
1.4M
EPS TTM
-111.00
Shares Outstanding
73.3M
EX-Date
12/26/08
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for AMINOLOGICS CO LTD (074430)

Related News

No related news articles were found.

aminologics co ltd (074430) Related Businessweek News

No Related Businessweek News Found

aminologics co ltd (074430) Details

Aminologics Co., Ltd, a specialty amino acid provider, develops a range of amino-acid-based raw materials for pharmaceutical and fine chemical industries. The company’s products include D-phenylalanine, D-alanine, D-cysteine, D-serine, D-allo-isoleucine, D-allo-threonine, S-beta-phenylalanine, 3-(2-napthyl)-D-alanine, and 4-chloro-D-phenylalanine, as well as API intermediates and API products. It also provides IT products, such as analog and digital integrated image processors for video security systems; and video image codec for use in network transmission, REW and FF playback, and play speed with I/P/Pi-frame referencing structure. The company was founded in 1997 and is headquartered in Seoul, South Korea. Aminologics Co., Ltd. is a subsidiary of Sam-Oh Pharm Co., Ltd.

Founded in 1997

aminologics co ltd (074430) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

aminologics co ltd (074430) Key Developments

Aminologics Co., Ltd., Annual General Meeting, Mar 27, 2015

Aminologics Co., Ltd., Annual General Meeting, Mar 27, 2015., at 09:00 Korea Standard Time. Location: Yangjae, aT Center. Agenda: To consider and approve the financial statements for the year ended December 31, 2014; to approve directors remuneration; and to approve audit remuneration.

Aminologics Co., Ltd., Special/Extraordinary Shareholders Meeting, Mar 27, 2014

Aminologics Co., Ltd., Special/Extraordinary Shareholders Meeting, Mar 27, 2014., at 09:00 Korea Standard Time. Location: Yangjaedong , aT Center. Agenda: To consider the appointment of election of directors; to consider election of auditor; and to consider any other business.

LG Life Sciences Not To Acquire Aminologics

LG Life Sciences, Ltd. (KOSE:A068870) has denied the rumors that it is planning to acquire Aminologics Co., Ltd. (KOSE:A074430).

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
074430:KS 1,410.00 KRW +40.00

074430 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 074430.
View Industry Companies
 

Industry Analysis

074430

Industry Average

Valuation 074430 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 24.2x
Price/Book 3.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 22.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMINOLOGICS CO LTD, please visit www.aminologics.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.